retatrutide phase 3 trials results for have been released, and the data are generating a lot of discussion in obesity medicine. TRIUMPH-1 enrolled 2,339 adults with obesity or overweight and followed participants for When does the first phase
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Lincoff A.M., Brown-Frandsen K., Colhoun H.M., Deanfield J., Emerson S.S., Esbjerg S., Hardt-Lindberg S., Hovingh G.K., Kahn S.E., Kushner R.F., et al
As a reminder, agonists attempt to mimic the molecules action, while antagonists attempt to block the molecules action
These results already beat many other weight loss medications available today
It's Already a Hit Plus, the early reviews say it all
The researchers included the costs of medication, other medical therapy, and worker productivity in their analysis
